Everence Capital Management Inc. Has $830,000 Stake in The Cooper Companies, Inc. (NASDAQ:COO)

Everence Capital Management Inc. decreased its position in The Cooper Companies, Inc. (NASDAQ:COO) by 9.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 9,024 shares of the medical device company’s stock after selling 900 shares during the quarter. Everence Capital Management Inc.’s holdings in Cooper Companies were worth $830,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in COO. GAMMA Investing LLC increased its position in Cooper Companies by 9.2% during the fourth quarter. GAMMA Investing LLC now owns 3,605 shares of the medical device company’s stock worth $331,000 after buying an additional 304 shares during the last quarter. Versant Capital Management Inc increased its holdings in shares of Cooper Companies by 306.6% during the 4th quarter. Versant Capital Management Inc now owns 988 shares of the medical device company’s stock valued at $91,000 after acquiring an additional 745 shares during the last quarter. JPMorgan Chase & Co. raised its stake in shares of Cooper Companies by 13.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock valued at $543,979,000 after acquiring an additional 573,908 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in Cooper Companies by 6.6% in the 3rd quarter. Principal Financial Group Inc. now owns 238,305 shares of the medical device company’s stock worth $26,295,000 after purchasing an additional 14,687 shares during the last quarter. Finally, Lord Abbett & CO. LLC lifted its holdings in Cooper Companies by 6.3% in the 3rd quarter. Lord Abbett & CO. LLC now owns 251,402 shares of the medical device company’s stock worth $27,740,000 after purchasing an additional 14,957 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on COO. Citigroup dropped their price target on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research report on Friday, December 6th. Wells Fargo & Company boosted their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Finally, Morgan Stanley decreased their target price on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Four research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $117.00.

Cooper Companies Stock Up 1.2 %

COO opened at $91.79 on Friday. The Cooper Companies, Inc. has a fifty-two week low of $84.76 and a fifty-two week high of $112.38. The company has a market capitalization of $18.32 billion, a P/E ratio of 47.07, a P/E/G ratio of 2.52 and a beta of 0.97. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The firm’s fifty day moving average price is $99.16 and its two-hundred day moving average price is $98.80.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. The business had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm’s revenue for the quarter was up 9.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.87 earnings per share. On average, analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.